TCL Archive In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers October 4, 1996
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013